LU91660I2 - Vinflunine et ses sels thérapeutiquement acceptables, en particulier le ditartrate - Google Patents

Vinflunine et ses sels thérapeutiquement acceptables, en particulier le ditartrate

Info

Publication number
LU91660I2
LU91660I2 LU91660C LU91660C LU91660I2 LU 91660 I2 LU91660 I2 LU 91660I2 LU 91660 C LU91660 C LU 91660C LU 91660 C LU91660 C LU 91660C LU 91660 I2 LU91660 I2 LU 91660I2
Authority
LU
Luxembourg
Prior art keywords
pct
acceptable salts
ditartrate
vinflunine
therapeutically acceptable
Prior art date
Application number
LU91660C
Other languages
English (en)
French (fr)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU91660(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of LU91660I2 publication Critical patent/LU91660I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU91660C 1993-07-21 2010-03-10 Vinflunine et ses sels thérapeutiquement acceptables, en particulier le ditartrate LU91660I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
PCT/FR1994/000898 WO1995003312A1 (fr) 1993-07-21 1994-07-19 Derives antimitotiques des alcaloides binaires du catharanthus roseus

Publications (1)

Publication Number Publication Date
LU91660I2 true LU91660I2 (fr) 2010-05-10

Family

ID=9449457

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91660C LU91660I2 (fr) 1993-07-21 2010-03-10 Vinflunine et ses sels thérapeutiquement acceptables, en particulier le ditartrate

Country Status (15)

Country Link
US (1) US5620985A (enExample)
EP (1) EP0710240B1 (enExample)
JP (1) JP3606872B2 (enExample)
AT (1) ATE146477T1 (enExample)
AU (1) AU693460B2 (enExample)
BR (1) BR1100311A (enExample)
CA (1) CA2167694C (enExample)
DE (2) DE122010000012I1 (enExample)
DK (1) DK0710240T3 (enExample)
ES (1) ES2097659T3 (enExample)
FR (2) FR2707988B1 (enExample)
GR (1) GR3022659T3 (enExample)
LU (1) LU91660I2 (enExample)
NZ (2) NZ269172A (enExample)
WO (1) WO1995003312A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
AU2004296191B2 (en) 2003-12-04 2010-10-28 Albany Molecular Research, Inc. Vinca derivatives
US7235564B2 (en) 2003-12-04 2007-06-26 Amr Technology, Inc. Vinorelbine derivatives
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US7422741B2 (en) 2004-03-05 2008-09-09 Vegenics Limited VEGFR-3 fusion proteins
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
EP1989212B1 (en) * 2006-02-17 2013-06-19 Cascade Prodrug Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
WO2008033935A2 (en) * 2006-09-12 2008-03-20 Amr Technology, Inc. Vinorelbine derivatives
WO2008033930A2 (en) * 2006-09-12 2008-03-20 Amr Technology, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
MX2011006890A (es) 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
EP2547359B1 (en) 2010-03-15 2016-03-09 The Board of Trustees of the University of Illionis Inhibitors of beta integrin-g protein alpha subunit binding interactions
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
US9029502B2 (en) 2010-12-20 2015-05-12 The Regents Of The University Of Michigan Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
US9783547B2 (en) 2014-01-15 2017-10-10 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
EP3250609A4 (en) 2015-01-26 2018-07-11 The University of Chicago Il13ra alpha 2 binding agents and use thereof in cancer treatment
EP3250611B1 (en) 2015-01-26 2021-04-21 The University of Chicago Car t-cells recognizing cancer-specific il 13r-alpha2
BR112018067637A2 (pt) * 2016-03-09 2019-01-02 Synbias Pharma Ag monotartrato de vinorelbina e seu uso farmacêutico
WO2018007554A1 (en) 2016-07-06 2018-01-11 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
CA3071599A1 (en) 2017-08-07 2019-02-14 Amgen Inc. Treatment of triple negative breast cancer or colorectal cancer with liver metastases with an anti pd-l1 antibody and an oncolytic virus
WO2020191344A1 (en) 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 bispecific antibodies
DK3941946T3 (da) 2019-03-20 2025-03-24 Univ California Claudin-6-antistoffer og lægemiddelkonjugater
AU2020266083A1 (en) 2019-04-30 2021-09-23 Instituto de Medicina Molecular João Lobo Antunes Rank pathway inhibitors in combination with CDK inhibitors
EP3962521A1 (en) 2019-05-02 2022-03-09 University of Florida Research Foundation, Inc. Compositions for treatment of diffuse intrinsic pontine glioma
MX2021015937A (es) 2019-06-24 2022-02-03 Amgen Inc Inhibicion de sirp-gamma para el tratamiento del cancer.
US12703750B2 (en) 2020-04-11 2026-08-11 Northwestern University Humanized antibody targeting the tumor associated antigen IL13Ra2
FR3140369B1 (fr) 2022-10-04 2025-07-25 Univ Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (enExample) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
JPH09500634A (ja) 1997-01-21
EP0710240A1 (fr) 1996-05-08
WO1995003312A1 (fr) 1995-02-02
FR2707988A1 (fr) 1995-01-27
DK0710240T3 (da) 1997-06-02
EP0710240B1 (fr) 1996-12-18
CA2167694A1 (fr) 1995-02-02
AU7266694A (en) 1995-02-20
ATE146477T1 (de) 1997-01-15
ES2097659T3 (es) 1997-04-01
AU693460B2 (en) 1998-07-02
CA2167694C (fr) 2007-03-06
BR1100311A (pt) 1999-08-31
DE69401216T2 (de) 1997-07-03
NZ269172A (en) 1997-10-24
JP3606872B2 (ja) 2005-01-05
FR2707988B1 (fr) 1995-10-13
NZ328612A (en) 2000-05-26
DE69401216D1 (de) 1997-01-30
US5620985A (en) 1997-04-15
GR3022659T3 (en) 1997-05-31
FR10C0012I1 (enExample) 2010-04-16
DE122010000012I1 (de) 2010-07-08
FR10C0012I2 (enExample) 2011-04-01

Similar Documents

Publication Publication Date Title
AU693460B2 (en) Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
DE69512930D1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
BG104899A (en) Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis
ZA955105B (en) Thiazolidine derivatives their preparation and compositions containing them
BR1100143A (pt) Composto, e, composição farmacêutica.
DE59108770D1 (de) Fluorverbindungen als Aromatase-Inhibitoren
NO961860L (no) Antracyklinderivater
HRP950437B1 (en) N-substituted azabicycloheptane derivatives, their production and use
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
NO304592B1 (no) Aminosyrer nyttige ved terapi av osteoartikulµre pÕvirkninger, farmas°ytiske blandinger og anvendelse derav
NO307706B1 (no) Substituerte aryltiolalkyltiopyridiner
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
AU5618699A (en) N-substituted azabicycloheptane derivatives, production and use thereof